These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16924461)

  • 1. [The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette's syndrome].
    Müller-Vahl KR
    Nervenarzt; 2007 Mar; 78(3):264, 266-8, 270-1. PubMed ID: 16924461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pimozide for tics in Tourette's syndrome.
    Pringsheim T; Marras C
    Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD006996. PubMed ID: 19370666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of tics in Tourette syndrome with atypical antipsychotic drugs].
    Sindø I; Jørgensen JI
    Ugeskr Laeger; 2002 Aug; 164(32):3755-9. PubMed ID: 12362607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of substituted benzamides on prolactin secretion in the rat.
    Kakigi T; Maeda K; Tanimoto K; Kaneda H; Shintani T
    Biol Psychiatry; 1992 Apr; 31(8):827-31. PubMed ID: 1353691
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pharmacology of dopamine-modulating agents in Tourette's syndrome.
    Mogwitz S; Buse J; Ehrlich S; Roessner V
    Int Rev Neurobiol; 2013; 112():281-349. PubMed ID: 24295625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors.
    Hermesh H; Huberman M; Radvan H; Kott E
    J Nerv Ment Dis; 1984 Nov; 172(11):692-5. PubMed ID: 6238132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of repeated tiapride administration on anterior pituitary dopamine receptors and prolactin release in the rat.
    Apud JA; Masotto C; Monopoli A; Ongini E; Rovescalli AC; Racagni G
    Pharmacol Res Commun; 1987 Feb; 19(2):119-29. PubMed ID: 3588649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of Tourette's syndrome: current opinions.
    Müller-Vahl KR
    Expert Opin Pharmacother; 2002 Jul; 3(7):899-914. PubMed ID: 12083990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute dyskinesias in monkeys elicited by halopemide, mezilamine and the "antidyskinetic" drugs, oxiperomide and tiapride.
    Neale R; Fallon S; Gerhardt S; Liebman JM
    Psychopharmacology (Berl); 1981; 75(3):254-7. PubMed ID: 6798615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological options for the treatment of Tourette's disorder.
    Jiménez-Jiménez FJ; García-Ruiz PJ
    Drugs; 2001; 61(15):2207-20. PubMed ID: 11772131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The preclinical pharmacologic profile of tiapride.
    Scatton B; Cohen C; Perrault G; Oblin A; Claustre Y; Schoemaker H; Sanger DJ; Rouquier L; Porsolt R
    Eur Psychiatry; 2001 Jan; 16 Suppl 1():29s-34s. PubMed ID: 11520476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of Tourette's disorder with amisulpride.
    Fountoulakis KN; Iacovides A; St Kaprinis G
    Ann Pharmacother; 2004 May; 38(5):901. PubMed ID: 15010520
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose amisulpride and elevation in serum prolactin.
    Andrade C
    J Clin Psychiatry; 2013 Jun; 74(6):e558-60. PubMed ID: 23842026
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuroleptic malignant syndrome caused by tiapride and neurologic complications].
    Perez Y; De Lacharriere O; Valcke JC; Benit C; Moreau L
    Presse Med; 1989 Mar; 18(11):585. PubMed ID: 2523061
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Gilles de la Tourette's disease with amisulpride].
    Trillet M; Moreau T; Daléry J; de Villard R; Aimard G
    Presse Med; 1990 Feb; 19(4):175. PubMed ID: 1968252
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of substituted benzamides on frog rectus abdominis.
    Fontaine J; Reuse J
    Eur J Pharmacol; 1980 Nov; 68(1):55-60. PubMed ID: 6969659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tiapride treatment of delirium tremens and the neuroleptic malignant syndrome].
    Ged E; Perrotin D; Lanotte R; Ginies G
    Presse Med; 1986 May; 15(22):1047-8. PubMed ID: 2942878
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride.
    Eggers C; Rothenberger A; Berghaus U
    Eur Arch Psychiatry Neurol Sci; 1988; 237(4):223-9. PubMed ID: 2974416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of tic disorders and Tourette Syndrome.
    Roessner V; Schoenefeld K; Buse J; Bender S; Ehrlich S; Münchau A
    Neuropharmacology; 2013 May; 68():143-9. PubMed ID: 22728760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptically induced dystonia in Huntington's disease: a case report.
    Schott K; Ried S; Stevens I; Dichgans J
    Eur Neurol; 1989; 29(1):39-40. PubMed ID: 2523309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.